SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-021958
Filing Date
2021-03-18
Accepted
2021-03-18 21:22:28
Documents
2
Period of Report
2021-03-18

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2678
2 POA DOCUMENT poa.txt EX-24.3_974424 3622
  Complete submission text file 0001209191-21-021958.txt   7703
Mailing Address 200 INNER BELT ROAD SOMERVILLE MA 02143
Business Address 200 INNER BELT ROAD SOMERVILLE MA 02143 617-229-6499
Finch Therapeutics Group, Inc. (Issuer) CIK: 0001733257 (see all company filings)

IRS No.: 823433558 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O HARPOON THERAPEUTICS, INC. 131 OYSTER POINT BOULEVARD, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address
Viney Joanne L. (Reporting) CIK: 0001816744 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40227 | Film No.: 21756295